Acquisition of Anesthetic and Injectable Medicines for the Surgical Specialties of the Heas

BoliviaTenders notice for Acquisition of Anesthetic and Injectable Medicines for the Surgical Specialties of the Heas. The reference ID of the tender is 116165290 and it is closing on 18 Mar 2025.

100% Secure Payments

Tender Details

  • Country: Bolivia
  • Summary: Acquisition of Anesthetic and Injectable Medicines for the Surgical Specialties of the Heas
  • BOT Ref No: 116165290
  • Deadline: 18 Mar 2025
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: 25-0902-34-1533188-1-1
  • Purchaser's Detail :
  • Purchaser : HEALTH ROBS - HOSPITAL EL ALTO SUR
    Roberto Carlos Ayllon Gironda (Telf 60541043)

  • Description :
  • The tenders are invited to the acquisition of anesthetic and injectable medicines for the surgical specialties of the Heas
    State: in force
    entity: Health Desperate - El Alto Sur Hospital
    Department: La Paz
    Publication date: March 11, 2025
    Modality: National Support to the
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
BoliviaTenders Features

BoliviaTenders Features

Fresh and verified Tenders from Bolivia. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Bolivia in your email inbox.

  Chat with us